A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challenge
一种减毒活RhCMV/SIV疫苗显示出对异源SIV攻击的长期疗效。
期刊:Science Translational Medicine
影响因子:14.6
doi:10.1126/scitranslmed.aaw2607
Hansen, Scott G; Marshall, Emily E; Malouli, Daniel; Ventura, Abigail B; Hughes, Colette M; Ainslie, Emily; Ford, Julia C; Morrow, David; Gilbride, Roxanne M; Bae, Jin Y; Legasse, Alfred W; Oswald, Kelli; Shoemaker, Rebecca; Berkemeier, Brian; Bosche, William J; Hull, Michael; Womack, Jennie; Shao, Jason; Edlefsen, Paul T; Reed, Jason S; Burwitz, Ben J; Sacha, Jonah B; Axthelm, Michael K; Früh, Klaus; Lifson, Jeffrey D; Picker, Louis J